About
Advancing Human Healing
A team built on trust, science, and a commitment to patients.
Since 2021, Sequence LifeScience™ has been dedicated to advancing human healing through innovative tissue processing, rigorous quality standards, and meaningful partnerships. Every product we manufacture reflects our commitment to the donors who made it possible and the patients who depend on it.
Our Expertise
Leadership
Sequence LifeScience is built on decades of combined expertise in tissue banking, regenerative biologics, orthopedic innovation, and quality systems.
Our leadership team brings together more than 60 years of collective industry experience — spanning FDA-regulated manufacturing, global sales strategy, and enterprise quality governance — united by a shared commitment to advancing human tissue science.
Founded within the Fountainhead Biomedical Holdings platform — alongside Nvision Biomedical Technologies and Lockhill Advanced Manufacturing Technologies — Sequence operates at the forefront of a vertically integrated ecosystem designed to accelerate the path from biomedical innovation to clinical adoption. Our team includes a Certified Tissue Bank Specialist (CTBS), a Six Sigma-credentialed quality executive, and leaders with proven track records in building and scaling medical technology companies from concept through commercialization.
LEADERSHIP
LEADERSHIP TEAM
Meet the experienced leaders guiding Sequence LifeScience with strategic vision, operational excellence, and a commitment to advancing regenerative biologics.
Quality And Regulatory
Sequence LifeScience maintains a robust Quality management System to ensure product safety, quality, and regulatory compliance. Our Quality program follows a Quality by Design approach to consistently meet applicable requirements.
We partner with select recovery organizations for donor screening, informed consent and collection and acquisition of the donated tissue. Sequence LifeScience also ensures its partners maintain compliance with FDA and the AATB.
Sequence LifeScience manufactures human cells, tissues and cellular and tissues based products that are regulated solely under the authority of section 361 as described in 21 CFR 1271.10.
Sequence LifeSciences’ products are processed in ISO Class 5 environments and our Quality Management Systems ensure the safety of the tissue for transplant.
Quality & Regulatory
Accreditations:
We are an FDA-registered tissue establishment, operating in full compliance with rigorous federal quality and safety standards.
Quality & Regulatory
Careers at
Sequence LifeScience:
Sequence LifeScience, Inc. is continuing to grow its team across key areas of the organization. Individuals interested in career opportunities are encouraged to review available openings and contact the company for additional information.
